Found: 14
Select item for more details and to access through your institution.
Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.703210
- By:
- Publication type:
- Article
A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01996-6
- By:
- Publication type:
- Article
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disulfiram‐copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 2, p. e46, doi. 10.1111/ajco.13551
- By:
- Publication type:
- Article
Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer.
- Published in:
- International Journal of Nanomedicine, 2020, v. 15, p. 5545, doi. 10.2147/IJN.S257522
- By:
- Publication type:
- Article
Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.632524
- By:
- Publication type:
- Article
Ferrocene‐Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.
- Published in:
- Small, 2023, v. 19, n. 2, p. 1, doi. 10.1002/smll.202205024
- By:
- Publication type:
- Article
Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00539
- By:
- Publication type:
- Article
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41419-024-06450-x
- By:
- Publication type:
- Article
Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 6149, doi. 10.2147/CMAR.S255817
- By:
- Publication type:
- Article
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01516-2
- By:
- Publication type:
- Article
The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3353, doi. 10.2147/OTT.S290284
- By:
- Publication type:
- Article
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.
- Published in:
- International Journal of Nanomedicine, 2024, v. 19, p. 3957, doi. 10.2147/IJN.S455355
- By:
- Publication type:
- Article